
Scott Long
Examiner (ID: 10754, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5153874
[patent_doc_number] => 20070036757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Aav vector for gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/560268
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6751
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20070036757.pdf
[firstpage_image] =>[orig_patent_app_number] => 10560268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/560268 | AAV vector for gene therapy | Jun 8, 2004 | Issued |
Array
(
[id] => 4652126
[patent_doc_number] => 20080039382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => 'Compositions related to pleiotrophin methods and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/857087
[patent_app_country] => US
[patent_app_date] => 2004-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12111
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10857087
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/857087 | Compositions related to pleiotrophin methods and uses thereof | May 27, 2004 | Abandoned |
Array
(
[id] => 13827
[patent_doc_number] => 07803782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-28
[patent_title] => 'Intravenous delivery of polynucleotides to cells in mammalian limb'
[patent_app_type] => utility
[patent_app_number] => 10/855175
[patent_app_country] => US
[patent_app_date] => 2004-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 16
[patent_no_of_words] => 18716
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/803/07803782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10855175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/855175 | Intravenous delivery of polynucleotides to cells in mammalian limb | May 26, 2004 | Issued |
Array
(
[id] => 7152797
[patent_doc_number] => 20050025821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Lipid-comprising drug delivery complexes and methods for their production'
[patent_app_type] => utility
[patent_app_number] => 10/850873
[patent_app_country] => US
[patent_app_date] => 2004-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 55675
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025821.pdf
[firstpage_image] =>[orig_patent_app_number] => 10850873
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/850873 | Lipid-comprising drug delivery complexes and methods for their production | May 19, 2004 | Abandoned |
Array
(
[id] => 7977077
[patent_doc_number] => 08071285
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-12-06
[patent_title] => 'Zinc finger protein derivatives and methods of using same'
[patent_app_type] => utility
[patent_app_number] => 10/843200
[patent_app_country] => US
[patent_app_date] => 2004-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6661
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/071/08071285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843200 | Zinc finger protein derivatives and methods of using same | May 10, 2004 | Issued |
Array
(
[id] => 7427515
[patent_doc_number] => 20040265880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Genomic and proteomic approaches for the development of cell culture medium'
[patent_app_type] => new
[patent_app_number] => 10/842649
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16548
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265880.pdf
[firstpage_image] =>[orig_patent_app_number] => 10842649
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/842649 | Genomic and proteomic approaches for the development of cell culture medium | May 9, 2004 | Abandoned |
Array
(
[id] => 5794030
[patent_doc_number] => 20060014711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/828831
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14431
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828831
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828831 | Methods for modulating expression of exogenous genes in mammalian systems, and products related thereto | Apr 19, 2004 | Abandoned |
Array
(
[id] => 211396
[patent_doc_number] => 07622302
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-11-24
[patent_title] => 'Process for improving the manufacture of clavams e.g. clavulanic acid'
[patent_app_type] => utility
[patent_app_number] => 10/552571
[patent_app_country] => US
[patent_app_date] => 2004-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9416
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552571 | Process for improving the manufacture of clavams e.g. clavulanic acid | Apr 12, 2004 | Issued |
Array
(
[id] => 4977276
[patent_doc_number] => 20070218509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Murine Living Tissue Model & UsesTthereof'
[patent_app_type] => utility
[patent_app_number] => 10/552607
[patent_app_country] => US
[patent_app_date] => 2004-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7377
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10552607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/552607 | Murine Living Tissue Model & UsesTthereof | Apr 4, 2004 | Abandoned |
Array
(
[id] => 5705230
[patent_doc_number] => 20060194278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Process for producing glucose dehydrogenase'
[patent_app_type] => utility
[patent_app_number] => 10/550671
[patent_app_country] => US
[patent_app_date] => 2004-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5641
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10550671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/550671 | Process for producing glucose dehydrogenase | Mar 23, 2004 | Abandoned |
Array
(
[id] => 5149480
[patent_doc_number] => 20070049540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor'
[patent_app_type] => utility
[patent_app_number] => 10/565283
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3745
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20070049540.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565283 | Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor | Mar 14, 2004 | Abandoned |
Array
(
[id] => 5141787
[patent_doc_number] => 20070004003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Koji mold-origin phospholipase a2'
[patent_app_type] => utility
[patent_app_number] => 10/547708
[patent_app_country] => US
[patent_app_date] => 2004-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9347
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547708
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547708 | Koji mold-origin phospholipase a2 | Mar 1, 2004 | Abandoned |
Array
(
[id] => 5100780
[patent_doc_number] => 20070184042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Method of cancer treatment by p53 protein control'
[patent_app_type] => utility
[patent_app_number] => 10/788489
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5472
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20070184042.pdf
[firstpage_image] =>[orig_patent_app_number] => 10788489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/788489 | Method of cancer treatment by p53 protein control | Feb 29, 2004 | Issued |
Array
(
[id] => 82613
[patent_doc_number] => 07740835
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Anaerobic bacterium as a drug for cancer gene therapy'
[patent_app_type] => utility
[patent_app_number] => 10/782899
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13555
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/740/07740835.pdf
[firstpage_image] =>[orig_patent_app_number] => 10782899
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/782899 | Anaerobic bacterium as a drug for cancer gene therapy | Feb 22, 2004 | Issued |
Array
(
[id] => 8163474
[patent_doc_number] => 08173162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Preparation for repairing cartilage tissue, especially articular cartilage defects'
[patent_app_type] => utility
[patent_app_number] => 10/547437
[patent_app_country] => US
[patent_app_date] => 2004-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 4128
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10547437
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/547437 | Preparation for repairing cartilage tissue, especially articular cartilage defects | Feb 22, 2004 | Issued |
Array
(
[id] => 7161493
[patent_doc_number] => 20050084916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Identification of the IkappaBNS protein and its products'
[patent_app_type] => utility
[patent_app_number] => 10/783994
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 21623
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084916.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783994
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783994 | Identification of the IkappaBNS protein and its products | Feb 19, 2004 | Abandoned |
Array
(
[id] => 5608497
[patent_doc_number] => 20060270013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways'
[patent_app_type] => utility
[patent_app_number] => 10/546139
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 24700
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546139
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546139 | Method for the production of evolved microorganisms which permit the generation or modification of metabolic pathways | Feb 16, 2004 | Abandoned |
Array
(
[id] => 5095158
[patent_doc_number] => 20070116767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Chitosan-microparticles for ifn gene delivery'
[patent_app_type] => utility
[patent_app_number] => 10/544145
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12993
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20070116767.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544145
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544145 | Chitosan-microparticles for ifn gene delivery | Feb 12, 2004 | Abandoned |
Array
(
[id] => 81159
[patent_doc_number] => 07745113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-29
[patent_title] => 'Use of islet 1 as a marker for isolating or generating stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/544053
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13507
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/745/07745113.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544053 | Use of islet 1 as a marker for isolating or generating stem cells | Feb 1, 2004 | Issued |
Array
(
[id] => 7687627
[patent_doc_number] => 20070107071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Use of regulatory sequences for specific, transient expression in neuronal determined cells'
[patent_app_type] => utility
[patent_app_number] => 10/543713
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 56
[patent_no_of_words] => 46640
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20070107071.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543713
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543713 | Use of regulatory sequences for specific, transient expression in neuronal determined cells | Jan 27, 2004 | Abandoned |